ChemicalBook >
製品カタログ >
API >
抗生物質 >
セファロスポリン >(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 物理性質
- 融点 :
- >169°C (dec.)
- 比重(密度) :
- 1.68±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- Hygroscopic, -20°C Freezer, Under inert atmosphere
- 溶解性:
- DMSO(微量)、メタノール(微量)
- 酸解離定数(Pka):
- 2.80±0.50(Predicted)
- 外見 :
- 個体
- 色:
- 淡い黄色から黄色
安全性情報
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 価格
もっと(2)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCC242830 |
Cefixime Ethyl Ester Sodium Salt (Cefixime EP Impurity F) |
79368-95-9 |
1mg |
¥63600 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCC242830 |
Cefixime Ethyl Ester Sodium Salt (Cefixime EP Impurity F) |
79368-95-9 |
10mg |
¥533700 |
2024-03-01 |
購入 |
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 化学特性,用途語,生産方法
使用
Cefixime Ethyl Ester is an ester impurity of the third generation cephalosporin antibiotic, Cefixime (C242800).
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 上流と下流の製品情報
原材料
準備製品
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 生産企業
Global( 64)Suppliers
79368-95-9()キーワード:
- 79368-95-9
- (6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
- [6R-[6α,7β(Z)]]-7-[[(2-AMino-4-thiazolyl)[(2-ethoxy-
- CefixiMe Ethyl Ester (CefixiMe EP IMpurity F)
- CefixiMe Ethyl Ester SodiuM Salt (CefixiMe EP IMpurity F)
- (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((2-ethoxy-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Cefixime Impurity 6(Cefixime EP Impurity F)
- Cefixime impurity 6/Cefixime EP Impurity F/Cefixime Ethyl Ester/(6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(2-ethoxy-2-oxoethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Cefixime Impuriy F
- Cefixime EP Imp F
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)-
- Cefixime Impurity F USP/EP/BP
- (6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid USP/EP/BP
- (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-ethoxy-2-oxoethoxy)iminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
- Cefixime Ethyl ester
- Cefixime Impurity F Sodium salt
- (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-((2-ethoxy-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (Cefixime Impurity)